BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia

  February 24, 2025

   · 

  2 min read
• Press Releases

  Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference

  February 24, 2025

   · 

  1 min read
• Press Releases

  Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors

  February 24, 2025

   · 

  5 min read
• Press Releases

  Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025

  February 24, 2025

   · 

  1 min read
• Press Releases

  Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer

  February 24, 2025

   · 

  5 min read
• Press Releases

  Rapport Therapeutics to Participate in Upcoming Investor Conferences

  February 24, 2025

   · 

  1 min read
• Press Releases

  Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44

  February 24, 2025

   · 

  7 min read
• Press Releases

  Avalo Therapeutics to Participate in Upcoming Investor Conferences

  February 24, 2025

   · 

  1 min read
• Press Releases

  Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors

  February 24, 2025

   · 

  20 min read
• Press Releases

  Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference

  February 24, 2025

   · 

  1 min read